Claris Advisors’s Boston Scientific BSX Stock Holding History

Claris Advisors’s Portfolio BSX Stock Details BSX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-76	Closed	-$6.37K	–	227
2024 Q3	$6.37K	Buy	+76	New	+$5.99K	﹤0.01%	253

Other funds holding BSX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Claris Advisors's BSX Position: Q4 2024 in Review

Claris Advisors sold out of Boston Scientific (BSX) in Q4 2024, closing a stake of 76 shares — an estimated $6.37K sold.

Claris Advisors first reported a position in BSX in Q3 2024 and held it in 1 quarter. The position peaked at $6.37K in Q3 2024. 1,512 funds tracked by Wall St. Rank hold BSX as of Q4 2024.

Claris Advisors reported no remaining Boston Scientific position as of Q4 2024 after selling out during the quarter.
Claris Advisors sold 76 Boston Scientific shares in Q4 2024, an estimated $6.37K.
Claris Advisors first reported a position in Boston Scientific in Q3 2024 and held it in 1 quarter.
Claris Advisors's Boston Scientific position peaked at $6.37K in Q3 2024.
1,512 funds tracked by Wall St. Rank held Boston Scientific as of Q4 2024.

Based on Claris Advisors's 13F filing for Q4 2024, filed 7 Feb 2025.